SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-040254
Filing Date
2023-02-15
Accepted
2023-02-15 16:33:10
Documents
15
Period of Report
2023-02-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d264518d8k.htm   iXBRL 8-K 30379
2 EX-1.1 d264518dex11.htm EX-1.1 174721
3 EX-5.1 d264518dex51.htm EX-5.1 9718
7 GRAPHIC g264518dsp43a.jpg GRAPHIC 3973
  Complete submission text file 0001193125-23-040254.txt   394569

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA iobt-20230215.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20230215_lab.xml EX-101.LAB 17265
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20230215_pre.xml EX-101.PRE 10828
9 EXTRACTED XBRL INSTANCE DOCUMENT d264518d8k_htm.xml XML 3296
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 23635828
SIC: 2834 Pharmaceutical Preparations